Abstract
To determine whether high doses of amikacin would prevent the development of resistance in clinical isolates, the serum bactericidal activity and killing rate of conventional and high doses of amikacin and piperacillin alone and in combination were measured in volunteer sera against a series of ten strains each of Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa.Amikacin serum levels were 24.9±6.0 mg/l 1 h after infusion of the 7.5 mg/kg dose and 44.8±5.0 mg/l after the two-fold dose. Median serum bactericidal titers for low dose piperacillin + amikacin were 1∶8–1∶64 and for high-dose piperacillin + amikacin 1∶16–1∶128. Both were satisfactory, except against piperacillin-resistant Pseudomonas aeruginosa (median bactericidal titers ⩽ 1∶2), and both combinations had equivalent killing rates.
Similar content being viewed by others
References
Klastersky, J., Zinner, S. H.: Synergistic combinations of antibiotics in gram-negative bacillary infections. Reviews of Infectious Diseases 1982, 4: 294–301.
EORTC International Antimicrobial Therapy Project Group: Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. Journal of Infectious Diseases 1978, 137: 14–29.
Klastersky, J., Vamecq, G., Cappel, R., Swing, G., Vandenborre, L.: Effect of combination of gentamicin and carbenicillin on the bactericidal activity of serum. Journal of Infectious Diseases 1972, 125: 183–186.
Carrizosa, J., Levison, E. M.: Minimal concentrations of aminoglycosides that can synergize with penicillin in enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 1981, 20: 405–409.
Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Schimpff, S. C., Greene, W. H., Calia, F. M., Hornick, R. B.: The carbenicillin-gentamicin combination againstPseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Annals of Internal Medicine 1974, 81: 584–587.
Klastersky, J., Daneau, D., Swing, G., Weerts, D.: Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. Journal of Infectious Diseases 1974, 129: 187–193.
Reller, L. B., Stratton, C. W.: Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. Journal of Infectious Diseases 1966, 136: 196–204.
Pearson, R. D., Steibigel, R. T., Davis, H. T., Champman, S.W.: Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrobial Agents and Chemotherapy 1980, 18: 699–708.
Bennet, J. V., Brodie, J. L., Benner, E. J., Kirby, W. M. M.: Simplified accurate method for antibiotic assay of clinical specimens. Applied Microbiology 1966, 14: 170–177.
Drake, T. A., Hackbarth, C. J., Sande, M. A.: Value of serum tests in combined drug therapy of endocarditis. Antimicrobial Agents and Chemotherapy 1983, 24: 653–657.
Reimer, L. G., Mirrett, S., Reller, L. B.: Comparison of in vitro activity of moxalactam, with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin and ticarcillin against 420 blood culture isolates. Antimicrobial Agents and Chemotherapy 1980, 17: 412–416.
White, G. W., Malow, J. B., Zimelis, V. M., Pahlavanzadeh, H., Panwalker, A. D., Jackson, G. G.: Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin and ticarcillin, alone and in combination with an aminoglycoside. Antimicrobial Agents and Chemotherapy 1979, 15: 540–543.
Follath, F., Wenk, M., Vozeh, S.: Plasma concentration monitoring of aminoglycosides. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement A: 37–43.
Moore, R. D., Smith, C. R., Lietman, P. S.: The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. Journal of Infectious Diseases 1984, 149: 443–448.
Lar, A., Lee, M., Flascha, S., Prasad, R., Sharifi, R.: Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function. Antimicrobial Agents and Chemotherapy 1983, 24: 533–537.
Moore, R. D., Smith, C. R., Lipsky, J. J., Mellits, E. D., Lietman, P. S.: Risk factors for nephrotoxicity in patients treated with aminoglycosides. Annals of Internal Medicine 1984, 100: 352–357.
Sculier, J. P., Klastersky, J.: Significance of the serum bactericidal test in gram-negative bacillary bacteremia in patients with and without granulocytopenia. American Journal of Medicine 1984, 76: 429–435.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lagast, H., Pascual-Lopez, A., Dejace, P. et al. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test. Eur. J, Clin. Microbiol. 5, 98–102 (1986). https://doi.org/10.1007/BF02013477
Issue Date:
DOI: https://doi.org/10.1007/BF02013477